ZEISS Group

Solutions that shape technological progress

Diagnose & Treat

Researching into Micro- and Nanostructures

See better

Assure Industrial Quality Excellence

Enabling Chip Manufacturers

Photograph & Film

Latest on the COVID-19 Situation

In response to the coronavirus pandemic, ZEISS has taken comprehensive measures to protect employees and maintain smart business continuity.

In order to continue supporting customers and partners as best as possible, at ZEISS we are doing everything we can to protect our employees’ health and safety as well as maintain production in our plants and ensure our service operations.

In January, ZEISS set up a dedicated task force. We are closely assessing the latest developments together with government agencies and healthcare authorities on an ongoing basis. Decisions are made daily regarding the most sensible measures for ZEISS to take.

Of course, we will continue to be available for our customers as best we can. Some employees in individual areas are currently working remotely but can still be reached at their usual phone numbers and email addresses.

However, should our customers experience any disruptions in service at some of our sites and sales offices, we can also be contacted on these numbers.

All over the world, the company and its employees are joining the fight against the spread and consequences of the coronavirus pandemic. Read more

Discover ZEISS

Fascinating insights into the world of optics

More than Just a Pair of Glasses:

How ZEISS Lenses Influenced Monet`s Creative Process

ZEISS SmartLife Lenses

News & Events

News from the ZEISS Group

17 December 2020

ZEISS Looks Back on Overall Good Fiscal Year 2019/20

Press Release

Overall, the ZEISS Group had a good fiscal year 2019/20: revenue totaled 6.297 billion euros (prior year: 6.428 billion euros). With a slight decline of 2% due to the COVID-19 pandemic, revenue almost reached last year's level.

11 December 2020

Carl Zeiss Meditec reports decline in revenue due to COVID-19 pandemic

Press Release

Carl Zeiss Meditec generated revenue of €1,335.5m in fiscal year 2019/20 (prior year: €1,459.3m), a decline of -8.5% (adjusted for currency effects: -8.7%) year on year. Earnings before interest and taxes (EBIT) decreased to €177.6m (prior year: €264.7m). The EBIT margin was 13.3% (prior year: 18.1%).

10 December 2020

BOSELLO HIGH TECHNOLOGY becomes Carl Zeiss X-ray Technologies Srl

Press Release

ZEISS and BOSELLO HIGH TECHNOLOGY (BOSELLO) announce that the Italian supplier of solutions for industrial X-ray systems, is now fully part of the ZEISS Group and will operate under the name Carl Zeiss X-ray Technologies Srl.